CAS RN: 80925-50-4

Ru(bpz)3(Cl)2

Product Availability

Choose a grade to view its available package options.

5 package records4 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260427 100mg In stock Shanghai Inquiry
Batchno.20260515 1g In stock Shanghai, Shenzhen, Tianjin, Wuhan, Chengdu Inquiry
Batchno.20250222 250mg In stock Shanghai, Wuhan, Chengdu Inquiry
Batchno.20250305 50mg In stock Shanghai, Shenzhen Inquiry
Batchno.20250423 5g Out of stock Inquiry
  • Product code: SSC-189544
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 1g
  • Available purity: ≥97%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 80925-50-4
Pack Size Recorded Purity Available Qty Ship From Inquiry
1g ≥97% 0 Out of Stock Hong Kong Inquiry

80925-50-4 / tris(2-pyrazin-2-ylpyrazine);ruthenium(2+);dichloride

Standard CAS: 80925-50-4 Multi CAS: Yes

Basic Information

CAS
80925-50-4
Multi CAS
Yes
Molecular Formula
C24H18CL2N12RU
Molecular Weight
646.500000
Exact Mass
646.019784
InChI
InChI=1S/3C8H6N4.2ClH.Ru/c3*1-3-11-7(5-9-1)8-6-10-2-4-12-8;;;/h3*1-6H;2*1H;/q;;;;;+2/p-2
InChIKey
XWSLUKLOHQAJCE-UHFFFAOYSA-L

Computed Properties

Structural Parameters

Heavy atom count
39
Aromatic heavy atom count
36
Rotatable bonds
3
H-bond acceptors
12
Molar refractivity
129.17
TPSA
154.68

LogP / Solubility

WLOGP
-3.19
MLOGP
-2.76
XLogP3
-3.19
Consensus LogP
-3.05
Log S (ESOL)
-2.32
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.56
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-1.57
Class (SILICOS-IT)
Soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-8.93

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
5.5

Get In Touch

Contact Us